Open Actively Recruiting

Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia

About

Brief Summary

The current pilot study will recruit participants experiencing new, returning, or ongoing symptoms related to COVID-19 illness for at least four weeks after being first infected with SARS-CoV-2. All participants will attend a virtual 6-week course entitled Mindful Awareness Practices (MAPs) created, hosted and led by expert facilitators from the Mindful Awareness Research Center (MARC) at University of California Los Angeles (UCLA). This intervention will consist of a mix of lecture, practice, group feedback, and discussion regarding mindfulness. Mindfulness is the mental state achieved by focusing one's awareness on the present while acknowledging and accepting any feelings, thoughts, or bodily sensations. The research team will collect self-reported measures of mental health symptoms, physical health symptoms, and demographic information before and after participants attend MAPs. Objective health measures will also be collected by the research team including an active stand test, a 6-minute walk, and a blood sample.

Primary Purpose
Supportive care
Study Type
Interventional
Phase
N/A

Eligibility

Gender
Female
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
54 Years

Inclusion Criteria:

Adult females (18 years - 54 years of age)

  • Previous SARS-CoV-2 infection confirmed by Polymerase chain reaction (PCR) testing and diagnoses of PASC and dysautonomia confirmed by objective testing (e.g., autonomic reflex screen, active stand test)
  • Ability to comprehend English and complete assessments and patient-reported surveys
  • Availability of a smartphone, tablet, or computer with Internet access

Exclusion Criteria:

  • Inability to participate in the virtual intervention or complete outcomes surveys
    • Current participation regular mindfulness practice
    • Current enrollment in another COVID-19 related study.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
22-001020
Category
Heart/Cardiovascular Diseases
Infectious Diseases
Contact
ELIZABETH VANDENBOGAART
Location
  • UCLA Westwood
For Providers
NCT No.
NCT05566379
For detailed technical eligibility, visit ClinicalTrials.gov.